Antifungals (Oral)
| Drug | Dosage | Remarks |
|---|---|---|
| Fluconazole | 150 mg PO once weekly Continue until infected nail is replaced |
Adverse Reactions
|
| Griseofulvin | 500-1,000 mg PO 24 hourly or in divided doses (at least 4 months for fingernails or 6 months for toenails) |
|
| Itraconazole | Continuous treatment: 200 mg PO 24 hourly x 3 months Pulse treatment: Fingernails only 200 mg PO 12 hourly x 1 week followed by a 3-week drug-free interval for 2 pulses Toenails with or without fingernail involvement 200 mg PO 12 hourly x 1 week followed by a 3-week drug-free interval x 3 pulses |
Adverse Reactions
|
| Ketoconazole | 200-400 mg PO 24 hourly x 6-12 months |
Adverse Reactions
|
| Terbinafine | Fingernail treatment: 250 mg PO 24 hourly x 6 weeks Toenail treatment: 250 mg PO 24 hourly x 12 weeks |
Adverse Reactions
|
Antifungals (Topical)
| Drug | Available Strength | Dosage | Remarks |
|---|---|---|---|
| Imidazoles | |||
| Clotrimazole1 | 1% lotion, cream | Rub on affected areas 8-12 hourly x 2-4 weeks |
Adverse Reactions
|
| Efinaconazole | 10% solution | Apply 24 hourly x 48 weeks |
Adverse Reactions
|
| Luliconazole | 1% cream; 5% solution | Apply 24 hourly |
Adverse Reactions
|
| Miconazole1 | 2% cream, tinct | Apply 24 hourly |
Adverse Reactions
|
| Tioconazole | 28% solution | Apply thinly 12 hourly x 6-12 months |
Adverse Reactions
|
| Others | |||
| Amorolfine | 5% nail lacquer | Apply 1-2x weekly until nail is regenerated and areas are cured |
Adverse Reactions
|
| Ciclopirox (Ciclopiroxolamine, Ciclopirox olamine) |
8% nail lacquer | Apply 48 hourly x 1 month, then twice weekly x 1 month, then once weekly for third month onwards until nail is regenerated and areas are cured Remove coating with alcohol once weekly |
Adverse Reactions
|
| Naftifine | 1% cream | Apply 24 hourly to affected nail |
Adverse Reactions
|
| Tavaborole | 5% solution | Apply 24 hourly x 48 weeks |
Adverse Reactions
|
| Terbinafine | 1% lotion, gel | Apply 24 hourly x 1-2 weeks |
Adverse Reactions
|
| 1Combination with a corticosteroid is available. Please see the latest MIMS for specific formulations and prescribing information. | |||
Disclaimer
All dosage recommendations are for non-pregnant and non-breastfeeding women, and non-elderly adults with normal renal and hepatic function unless otherwise stated.
Not all products are available or approved for above use in all countries.
Products listed in the Drug Summary are based on indications stated in the locally approved product monographs.
Please refer to local product monographs in Related MIMS Drugs for country-specific prescribing information.
Not all products are available or approved for above use in all countries.
Products listed in the Drug Summary are based on indications stated in the locally approved product monographs.
Please refer to local product monographs in Related MIMS Drugs for country-specific prescribing information.
